RYTM - Rhythm Pharma Profit before interest, taxes and amortization
Commercial expansion of innovative drugs for rare forms of obesity is driving growth, as evidenced by the operating profit of Rhythm Pharmaceuticals (RYTM). This trend is supported by targeted therapy for genetic malfunctions and synergy with global laboratories. The value of 0.00 represents the current metric level, capturing the business's real cash flow excluding accounting adjustments.
Summary analytical data breakdowns for Rhythm Pharmaceuticals, Inc. (RYTM)
- current quotes and average value forecast:
- market capitalization statistics:
- book capitalization data:
- company total debt and liquidity indicators:
Debt to Equity Rhythm Pharmaceuticals|RYTM - Long-Term Debt to Equity|Current Liabilities to Capital Rhythm Pharma|RYTM - Company Debts|Debt to Book Capitalization Ratio Rhythm Pharmaceuticals|RYTM - Company Long-Term Debts|Short-Term Debt Volume Rhythm Pharmaceuticals|Interim Coverage Ratio rhythmtx.com
- financial results and valuation multiples details:
RYTM - Company Net Income|Future Profit Rhythm Pharmaceuticals|RYTM - Price to Earnings Ratio|Future Price to Earnings Multiple rhythmtx.com|RYTM - PEG Multiple|Business Value to Operating Income Before Depreciation Rhythm Pharmaceuticals|RYTM - Operating profit before deduction of amortization|Net earnings per one share for the last twelve months Rhythm Pharmaceuticals|RYTM - Net earnings per share for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months rhythmtx.com|RYTM - Earnings growth in current year|Expected earnings per share trend next year Rhythm Pharmaceuticals
Analysis of all company metrics:Rhythm Corp (RYTM)
Developing innovative treatments for genetic obesity requires colossal expenditures, making the ability of Rhythm Pharmaceuticals (RYTM) to generate cash flow critically important. This EBITDA chart captures operating profit before depreciation and interest, measuring the core business efficiency and its capacity to service debt amid tight Fed policy, as clearly illustrated by the price action.
Who Rhythm Pharmaceuticals competes with
ASND - Operating profit before deduction of amortization|Madrigal Pharmaceuticals - Operating profit EBITDA|Profit before interest, taxes and amortization corcept.com|AKRO (Akero) - Operating profit before deduction of amortization|MTSR: Company profit before taxes, interest and amortization|MLTX (MoonLake Pharma) - Operating profit EBITDA|Operating profit EBITDA Crinetics Corp|Operating profit EBITDA NAMS|Profit before payment of interest, taxes and amortization SLNO (soleno.life)|Profit before payment of interest, taxes and amortization Amicus Therapeutics, Inc. FOLD|89bio Inc (ETNB) - Profit before interest, taxes and amortization|AGIO - Profit before payment of interest, taxes and amortization|GPCR: Profit before payment of interest, taxes and amortization|MDXG: Operating profit EBITDA|RZLT - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Lexicon Pharmaceuticals, Inc.|MBX Biosciences, Inc. (MBX) - Operating income before deduction of amortization|Profit before payment of interest, taxes and amortization Altimmune Corp (ALT)|Operating profit before deduction of amortization Aardvark Pharma AARD|Profit before payment of interest, taxes and amortization Sagimet Biosciences SGMT|Income before deduction of interest, taxes and amortization BIOA|Biomea Fusion - Operating profit EBITDA|Income before deduction of interest, taxes and amortization QNCX (Quince Therapeutics)|GUTS (Fractyl) - Operating profit before deduction of amortization|Profit before interest, taxes and amortization vTv Therapeutics (VTVT)|Operating profit before deduction of amortization ATPC|PLUR (Pluri Inc) - Company profit before taxes, interest and amortization|Operating profit EBITDA SYBX|LPCN (Lipocine Inc) - Income before deduction of interest, taxes and amortization|Profit before payment of interest, taxes and amortization Matinas BioPharma Holdings MTNB|SPRB - Operating profit before deduction of amortization|GLTO: Operating profit before deduction of amortization|Income before deduction of interest, taxes and amortization CTCX (carmellrx.com)|Lumos Pharma (LUMO) - Profit before payment of interest, taxes and amortization|Profit before deduction of interest, taxes, depreciation and amortization ONVO (Organovo Holdings)|RDUS (Radius Health) - Operating profit EBITDA
